(Q39584342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Koichi Oshita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Kunihiro Yamaoka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Nobuyuki Udagawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Shunsuke Fukuyo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Koshiro Sonomoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ryuji Kurihara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Kazuhisa Nakano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Kazuyoshi Saito

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Yosuke Okada

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Kenji Chiba

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Yoshiya Tanaka

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

1658-1667

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21360521%20AND%20SRC:MED&resulttype=core&format=json

Osteoimmunology and the effects of the immune system on bone

23 January 2020

cites work

1 reference

Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis

21 January 2018

1 reference

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

Why are MSCs therapeutic? New data: new insight.

21 January 2018

1 reference

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

21 January 2018

1 reference

Multipotent mesenchymal stromal cells and immune tolerance

21 January 2018

1 reference

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 January 2018

1 reference

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system

21 January 2018

1 reference

Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

21 January 2018

1 reference

Prostaglandin E2 strongly inhibits human osteoclast formation

21 January 2018

1 reference

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

21 January 2018

1 reference

IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression

21 January 2018

1 reference

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

21 January 2018

1 reference

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis

21 January 2018

1 reference

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors

21 January 2018

1 reference

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

21 January 2018

1 reference

Therapeutic implications of osteoprotegerin

21 January 2018

1 reference

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

21 January 2018

1 reference